Jammu to pioneer India’s first Cannabis Medicine Project

The ‘Cannabis Research Project’ of CSIR-IIIM Jammu, spearheaded by Prime Minister Narendra Modi, marks the first-ever initiative of its kind in India. This groundbreaking project is carried out in partnership with a Canadian firm ‘IndusScan’ with the aim of harnessing the potential of cannabis, a substance known for its abuse potential, for the benefit of humanity, particularly for patients afflicted with neuropathies, cancer, and epilepsy.

The Historic Collaboration Between CSIR-IIIM and IndusScan

The historic scientific agreement signed between CSIR-IIIM and IndusScan holds immense significance not only for J&K but also for the entire nation. It has the potential to revolutionize medicine production, ensuring that the country can produce and export medicines that were previously sourced from foreign countries.

This project will play a significant role in raising awareness about the diverse medicinal applications of this once-abused substance, particularly in providing relief to patients suffering from malignancies and various other diseases.

From the perspective of Atma-Nirbhar Bharat (self-reliant India), once all the necessary approvals are obtained, this initiative will enable the production of high-quality drugs suitable for treating different types of neuropathies, diabetic pains, and more, fostering self-sufficiency in the pharmaceutical sector.

CSIR-IIIM: Pioneering Scientific Research in India

CSIR-IIIM, the oldest scientific research institute in India, boasts a rich history of groundbreaking discoveries, including the identification of mint in the 1960s and its pivotal role in the purple revolution. Now, with the advent of the Cannabis Research Project, CSIR-IIIM is poised to elevate its status even further, cementing its position as a prestigious hub for scientific research in India.

Advancements in Medical Cannabis

Cannabis, a remarkable plant, has led to the approval of several drugs by the FDA, including Marilnol/nabilone and Cesamet, prescribed for managing nausea and vomiting. Sativex is another FDA-approved drug that utilizes cannabis for treating neuropathic pain and spasticity, while Epidiolex, containing Cannabidiol, has shown promising results in treating epilepsy. Furthermore, cannabis is being utilized for various medical purposes in other countries as well.

Key takeaways for competitive examinations

  • Chief Scientist at CSIR-IIIM Jammu: Dr Zabeer Ahmed

Find More Miscellaneous News Here

saurabh

Recent Posts

China Launches Shenzhou 23 Mission with Three Astronauts for Major Tiangong Space Station Mission

China has launched the Shenzhou 23 spacecraft and sent the three astronauts to its Tiangong…

3 hours ago

Sansad Ratna Awards 2026 Explained: Full Winners List and Why the Parliamentary Honour Matters

For the year 2026, the Sansad Ratna Awards have been announced the outstanding performance by…

3 hours ago

IPL 2026 Playoffs Explained: Qualified Teams, Final Standings, and Rajasthan Royals Qualification

As the IPL now at the climax part, final 4 teams are now officially confirmed…

3 hours ago

Lionel Messi Becomes Billionaire, Joining Cristiano Ronaldo in Historic Football Milestone

Football Icon Lionel Messi has officially enters to the billionaire club and become the only…

4 hours ago

Raghav Chadha Appointed Chairman of Rajya Sabha Committee on Petitions

Rajya Sabha MP Raghav Chadha has been appointed as the new Chairman of the Rajya…

4 hours ago

Indian Army Officer Major Abhilasha Barak Wins Prestigious UN Military Gender Advocate Award

Major Abhilasha Barak who was serving with the United Nations peacekeeping mission in Lebanon has…

5 hours ago